Exposure of phosphatidylserine on the cell surface

Cell Death and Differentiation

Volumn 23, Issue 6, 2016, Pages 952-961

  Nagata, S ^a   Suzuki, J ^a   Segawa, K ^a   Fujii, T ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATP11A PROTEIN; ATP11C PROTEIN; ATP8A2 PROTEIN; CALCIUM ION; CARRIER PROTEIN; CASPASE 3; CASPASE 7; FLIPPASE; MEMBRANE PROTEIN; PHOSPHATIDYLSERINE; SCRAMBLASE; THROMBIN; TMEM16F PROTEIN; UNCLASSIFIED DRUG; XK RELATED PROTEIN 8; ABC TRANSPORTER; APOPTOSIS REGULATORY PROTEIN; CASPASE; PHOSPHOLIPID TRANSFER PROTEIN;

APOPTOSIS; CALCIUM CELL LEVEL; CELL GROWTH; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; DOWN REGULATION; EUKARYOTIC CELL; HUMAN; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PYROPTOSIS; REVIEW; SCOTT SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE ACTIVATION; ANIMAL; CHEMISTRY; CYTOLOGY; METABOLISM; PHYSIOLOGY; THROMBOCYTE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD PLATELETS; CASPASES; CELL MEMBRANE; HUMANS; PHOSPHATIDYLSERINES; PHOSPHOLIPID TRANSFER PROTEINS;

EID: 84958824532     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2016.7     Document Type: Review

References (133)

1. Van Meer G, Voelker D, Feigenson G. Membrane lipids: Where they are and how they behave. Nat Rev Mol Cell Biol 2008; 9: 112-124
2. Leventis PA, Grinstein S. The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys 2010; 39: 407-427
3. Balasubramanian K, Schroit AJ. Aminophospholipid asymmetry: A matter of life and death. Annu Rev Physiol 2003; 65: 701-734
4. Seigneuret M, Devaux P. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: Relation to shape changes. Proc Natl Acad Sci USA 1984; 81: 3751-3755
5. Zachowski A, Henry JP, Devaux PF. Control of transmembrane lipid asymmetry in chromaffin granules by an ATP-dependent protein. Nature 1989; 340: 75-76
6. Moriyama Y, Nelson N. Purification and properties of a vanadate- and N-ethylmaleimidesensitive ATPase from chromaffin granule membranes. J Biol Chem 1988; 263: 8521-8527
7. Tang X, Halleck MS, Schlegel RA, Williamson P. A subfamily of P-type ATPases with aminophospholipid transporting activity. Science 1996; 272: 1495-1497
8. Paulusma C, Oude Elferink R. The type 4 subfamily of P-type ATPases, putative aminophospholipid translocases with a role in human disease. Biochim Biophys Acta 2005; 1741: 11-24
9. Folmer D, Elferink R, Paulusma C. P4 ATPases lipid flippases and their role in disease. Biochim Biophys Acta 2009; 1791: 628-635
10. Halleck MS, Pradhan D, Blackman C, Berkes C, Williamson P, Schlegel RA. Multiple members of a third subfamily of P-type ATPases identified by genomic sequences and ESTs. Genome Res 1998; 8: 354-361
11. Tanaka K, Fujimura-Kamada K, Yamamoto T. Functions of phospholipid flippases. J Biochem 2011; 149: 131-143
12. Panatala R, Hennrich H, Holthuis JC. Inner workings and biological impact of phospholipid flippases. J Cell Sci 2015; 128: 2021-2032
13. Saito K, Fujimura-Kamada K, Furuta N, Kato U, Umeda M, Tanaka K. Cdc50p, a protein required for polarized growth, associates with the Drs2p P-type ATPase implicated in phospholipid translocation in Saccharomyces cerevisiae. Mol Biol Cell 2004; 15: 3418-3432
14. Lenoir G, Williamson P, Puts CF, Holthuis JCM. Cdc50p plays a vital role in the ATPase reaction cycle of the putative aminophospholipid transporter Drs2p. J Biol Chem 2009; 284: 17956-17967
15. Hua Z, Fatheddin P, Graham TR. An essential subfamily of Drs2p-related P-type ATPases is required for protein trafficking between Golgi complex and endosomal/vacuolar system. Mol Biol Cell 2002; 13: 3162-3177
16. Lee S, Uchida Y, Wang J, Matsudaira T, Nakagawa T, Kishimoto T et al. Transport through recycling endosomes requires EHD1 recruitment by a phosphatidylserine translocase. EMBO J 2015; 34: 669-688
17. Siegmund A, Grant A, Angeletti C, Malone L, Nichols JW, Rudolph HK. Loss of Drs2p does not abolish transfer of fluorescence-labeled phospholipids across the plasma membrane of Saccharomyces cerevisiae. J Biol Chem 1998; 273: 34399-34405
18. Pomorski T, Lombardi R, Riezman H, Devaux PF, Van Meer G, Holthuis JCM. Drs2prelated P-type ATPases Dnf1p and Dnf2p are required for phospholipid translocation across the yeast plasma membrane and serve a role in endocytosis. Mol Biol Cell 2003; 14: 1240-1254
19. Stevens HC, Malone L, Nichols JW. The putative aminophospholipid translocases, DNF1 and DNF2, are not required for 7-nitrobenz-2-oxa-1, 3-diazol-4-yl-phosphatidylserine flip across the plasma membrane of Saccharomyces cerevisiae. J Biol Chem 2008; 283: 35060-35069
20. Darland-Ransom M, Wang X, Sun CL, Mapes J, Gengyo-Ando K, Mitani S et al. Role of C. elegans TAT-1 protein in maintaining plasma membrane phosphatidylserine asymmetry. Science 2008; 320: 528-531
21. Chen B, Jiang Y, Zeng S, Yan J, Li X, Zhang Y et al. Endocytic sorting and recycling require membrane phosphatidylserine asymmetry maintained by TAT-1/CHAT-1. PLoS Genet 2010; 6: E1001235
22. Segawa K, Kurata S, Yanagihashi Y, Brummelkamp T, Matsuda F, Nagata S. Caspasemediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure. Science 2014; 344: 1164-1168
23. Kotecki M, Reddy PS, Cochran BH. Isolation and characterization of a near-haploid human cell line. Exp Cell Res 1999; 252: 273-280
24. Carette JE, Guimaraes CP, Wuethrich I, Blomen VA, Varadarajan M, Sun C et al. Global gene disruption in human cells to assign genes to phenotypes by deep sequencing. Nat Biotechnol 2011; 29: 542-546
25. Segawa K, Kurata S, Nagata S. Human type IV P-type ATPases that work as plasma membrane phospholipid flippases, and their regulation by caspase and calcium. J Biol Chem 2016; 291: 762-772
26. Bitbol M, Fellmann P, Zachowski A, Devaux PF. Ion regulation of phosphatidylserine and phosphatidylethanolamine outside-inside translocation in human erythrocytes. Biochim Biophys Acta 1987; 904: 268-282
27. Luthi AU, Martin SJ. The CASBAH: A searchable database of caspase substrates. Cell Death Differ 2007; 14: 641-650
28. Martin SJ, Finucane DM, Amarante-Mendes GP, O'Brien GA, Green DR. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem 1996; 271: 28753-28756
29. Bratton DL, Fadok VA, Richter DA, Kailey JM, Guthrie LA, Henson PM. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J Biol Chem 1997; 272: 26159-26165
30. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995; 182: 1597-1601
31. Van den Eijnde SM, Boshart L, Baehrecke EH, De Zeeuw CI, Reutelingsperger CP, Vermeij-Keers C. Cell surface exposure of phosphatidylserine during apoptosis is phylogenetically conserved. Apoptosis 1998; 3: 9-16
32. Venegas V, Zhou Z. Two alternative mechanisms that regulate the presentation of apoptotic cell engulfment signal in Caenorhabditis elegans. Mol Biol Cell 2007; 18: 3180-3192
33. Tung TT, Nagaosa K, Fujita Y, Kita A, Mori H, Okada R et al. Phosphatidylserine recognition and induction of apoptotic cell clearance by Drosophila engulfment receptor Draper. J Biochem 2013; 153: 483-491
34. Bevers EM, Comfurius P, Zwaal RF. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736: 57-66
35. Bevers EM, Comfurius P, Zwaal RF. Platelet procoagulant activity: Physiological significance and mechanisms of exposure. Blood Rev 1991; 5: 146-154
36. Basse F, Stout JG, Sims PJ, Wiedmer T. Isolation of an erythrocyte membrane protein that mediates Ca2+-dependent transbilayer movement of phospholipid. J Biol Chem 1996; 271: 17205-17210
37. Zhou Q, Zhao J, Stout J, Luhm R, Wiedmer T, Sims P. Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem 1997; 272: 18240-18244
38. Bevers EM, Williamson PL. Phospholipid scramblase: An update. FEBS Lett 2010; 584: 2724-2730
39. Sahu S, Gummadi S, Manoj N, Aradhyam G. Phospholipid scramblases: An overview. Arch Biochem Biophys 2007; 462: 103-114
40. Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010; 468: 834-838
41. Brunner JD, Lim NK, Schenck S, Duerst A, Dutzler R. X-ray structure of a calcium-activated TMEM16 lipid scramblase. Nature 2014; 516: 207-212
42. Suzuki T, Suzuki J, Nagata S. Functional swapping between transmembrane proteins TMEM16A and TMEM16F. J Biol Chem 2014; 289: 7438-7447
43. Galietta L. The TMEM16 protein family: A new class of chloride channels?. Biophys J 2009; 97: 3047-3053
44. Yang Y, Cho H, Koo J, Tak M, Cho Y, Shim W et al. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature 2008; 455: 1210-1215
45. Schroeder B, Cheng T, Jan Y, Jan L. Expression cloning of TMEM16A as a calciumactivated chloride channel subunit. Cell 2008; 134: 1019-1029
46. Caputo A, Caci E, Ferrera L, Pedemonte N, Barsanti C, Sondo E et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 2008; 322: 590-594
47. Hartzell HC, Yu K, Xiao Q, Chien LT, Qu Z. Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels. J Physiol 2009; 587: 2127-2139
48. Flores CA, Cid LP, Sepúlveda FV, Niemeyer MI. TMEM16 proteins: The long awaited calcium-activated chloride channels?. Braz J Med Biol Res 2009; 42: 993-1001
49. Schreiber R, Uliyakina I, Kongsuphol P, Warth R, Mirza M, Martins J et al. Expression and function of epithelial anoctamins. J Biol Chem 2010; 285: 7838-7845
50. Shimizu T, Iehara T, Sato K, Fujii T, Sakai H, Okada Y. TMEM16F is a component of a Ca2+-activated Cl- channel but not a volume-sensitive outwardly rectifying Cl- channel. Am J Physiol Cell Physiol 2013; 304: C748-C759
51. Yang H, Kim A, David T, Palmer D, Jin T, Tien J et al. TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation. Cell 2012; 151: 111-122
52. Kunzelmann K, Nilius B, Owsianik G, Schreiber R, Ousingsawat J, Sirianant L et al. Molecular functions of anoctamin 6 (TMEM16F): A chloride channel, cation channel, or phospholipid scramblase?. Pflug Arch Eur J Phy 2014; 466: 407-414
53. Suzuki J, Fujii T, Imao T, Ishihara K, Kuba H, Nagata S. Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. J Biol Chem 2013; 288: 13305-13316
54. Yu K, Whitlock JM, Lee K, Ortlund EA, Yuan Cui Y, Hartzell HC. Identification of a lipid scrambling domain in ANO6/TMEM16F. eLife 2015; 4: E06901
55. Scudieri P, Caci E, Venturini A, Sondo E, Pianigiani G, Marchetti C et al. Ion channel and lipid scramblase activity associated with expression of tmem16F/ANO6 isoforms. J Physiol 2015; 593: 3829-3848
56. Wang Y, Alam T, Hill-Harfe K, Lopez AJ, Leung CK, Iribarne D et al. Phylogenetic, expression, and functional analyses of anoctamin homologs in Caenorhabditis elegans. Am J Physiol Regul Integr Comp Physiol 2013; 305: R1376-R1389
57. Milenkovic VM, Brockmann M, Stöhr H, Weber BH, Strauss O. Evolution and functional divergence of the anoctamin family of membrane proteins. BMC Evol Biol 2010; 10: 319
58. Li Z, Venegas V, Nagaoka Y, Morino E, Raghavan P, Audhya A et al. Necrotic cells actively attract phagocytes through the collaborative action of two distinct PS-exposure mechanisms. PLoS Genet 2015; 11: E1005285
59. Yu K, Duran C, Qu Z, Cui Y-y, Hartzell HC. Explaining calcium-dependent gating of anoctamin-1 chloride channels requires a revised topology. Circ Res 2012; 110: 990-999
60. Gu X. A simple statistical method for estimating type-II (cluster-specific) functional divergence of protein sequences. Mol Biol Evol 2006; 23: 1937-1945
61. Carafoli E. Calcium pump of the plasma membrane. Physiol Rev 1991; 71: 129-153
62. Hussain JF, Mahaut-Smith MP. Reversible and irreversible intracellular Ca2+ spiking in single isolated human platelets. J Physiol 1999; 514: 713-718
63. Marsault R, Murgia M, Pozzan T, Rizzuto R. Domains of high Ca2+ beneath the plasma membrane of living A7r5 cells. EMBO J 1997; 16: 1575-1581
64. Williamson P, Christie A, Kohlin T, Schlegel RA, Comfurius P, Harmsma M et al. Phospholipid scramblase activation pathways in lymphocytes. Biochemistry 2001; 40: 8065-8072
65. Schoenwaelder SM, Yuan Y, Josefsson EC, White MJ, Yao Y, Mason KD et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 2009; 114: 663-666
66. Suzuki J, Denning DP, Imanishi E, Horvitz HR, Nagata S. Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells. Science 2013; 341: 403-406
67. Fadeel B, Gleiss B, Högstrand K, Chandra J, Wiedmer T, Sims PJ et al. Phosphatidylserine exposure during apoptosis is a cell-type-specific event and does not correlate with plasma membrane phospholipid scramblase expression. Biochem Biophys Res Commun 1999; 266: 504-511
68. Fadok VA, De Cathelineau A, Daleke DL, Henson PM, Bratton DL. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J Biol Chem 2001; 276: 1071-1077
69. Calenda G, Peng J, Redman CM, Sha Q, Wu X, Lee S. Identification of two new members, XPLAC and XTES, of the XK family. Gene 2006; 370: 6-16
70. Suzuki J, Imanishi E, Nagata S. Exposure of phosphatidylserine by Xk-related protein family members during apoptosis. J Biol Chem 2014; 289: 30257-30267
71. Chen Y-Z, Mapes J, Lee E-S, Skeen-Gaar RR, Xue D. Caspase-mediated activation of Caenorhabditis elegans CED-8 promotes apoptosis and phosphatidylserine externalization. Nat Commun 2013; 4: 1-9
72. Rich T, Watson CJ, Wyllie A. Apoptosis: The germs of death. Nat Cell Biol 1999; 1: E69-E71
73. Berghe TV, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: The expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014; 15: 135-147
74. Brouckaert G, Kalai M, Krysko DV, Saelens X, Vercammen D, Ndlovu MN et al. Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol Biol Cell 2004; 15: 1089-1100
75. Krysko DV, Denecker G, Festjens N, Gabriels S, Parthoens E, D'Herde K et al. Macrophages use different internalization mechanisms to clear apoptotic and necrotic cells. Cell Death Differ 2006; 13: 2011-2022
76. Wang Q, Imamura R, Motani K, Kushiyama H, Nagata S, Suda T. Pyroptotic cells externalize eat-me and release find-me signals and are efficiently engulfed by macrophages. Int Immunol 2013; 25: 363-372
77. Nagata S, Hanayama R, Kawane K. Autoimmunity and the clearance of dead cells. Cell 2010; 140: 619-630
78. Segawa K, Suzuki J, Nagata S. Constitutive exposure of phosphatidylserine on viable cells. Proc Natl Acad Sci USA 2011; 108: 19246-19251
79. Segawa K, Nagata S. An apoptotic 'eat me' signal: Phosphatidylserine exposure. Trends Cell Biol 2015; 25: 649-650
80. Kornberg RD, McConnell HM. Inside-outside transitions of phospholipids in vesicle membranes. Biochemistry 1971; 10: 1111-1120
81. Nakano M, Fukuda M, Kudo T, Matsuzaki N, Azuma T, Sekine K et al. Flip-Flop of phospholipids in vesicles: Kinetic analysis with time-resolved small-angle neutron scattering. J Physical Chem B 2009; 113: 6745-6748
82. Driscoll M, Chalfie M. The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutate to induce neuronal degeneration. Nature 1991; 349: 588-593
83. Bianchi L, Gerstbrein B, Frøkjær-Jensen C, Royal DC, Mukherjee G, Royal MA et al. The neurotoxic MEC-4(d) DEG/ENaC sodium channel conducts calcium: Implications for necrosis initiation. Nat Neurosci 2004; 7: 1337-1344
84. Cai Z, Jitkaew S, Zhao J, Chiang H-C, Choksi S, Liu J et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 2014; 16: 55-65
85. Bergsbaken T, Fink SL, den Hartigh AB, Loomis WP, Cookson BT. Coordinated host responses during pyroptosis: Caspase-1-dependent lysosome exocytosis and inflammatory cytokine Maturation. J Immunol 2011; 187: 2748-2754
86. Siggs OM, Schnabl B, Webb B, Beutler B. X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C. Proc Nat Acad Sci USA 2011; 108: 7890-7895
87. Siggs OM, Arnold CN, Huber C, Pirie E, Xia Y, Lin P et al. The P4-type ATPase ATP11C is essential for B lymphopoiesis in adult bone marrow. Nat Immunol 2011; 12: 434-440
88. Yabas M, Teh CE, Frankenreiter S, Lal D, Roots CM, Whittle B et al. ATP11C is critical for the internalization of phosphatidylserine and differentiation of B lymphocytes. Nat Immunol 2011; 12: 441-449
89. Yabas M, Coupland LA, Cromer D, Winterberg M, Teoh NC, D'Rozario J et al. Mice deficient in the putative phospholipid flippase ATP11C exhibit altered erythrocyte shape, anemia, and reduced erythrocyte life span. J Biol Chem 2014; 289: 19531-19537
90. Manno S, Takakuwa Y, Mohandas N. Identification of a functional role for lipid asymmetry in biological membranes: Phosphatidylserine-skeletal protein interactions modulate membrane stability. Proc Nat Acad Sci USA 2002; 99: 1943-1948
91. Matsuzaka Y, Hayashi H, Kusuhara H. Impaired hepatic uptake by organic aniontransporting polypeptides is associated with hyperbilirubinemia and hypercholanemia in Atp11c mutant mice. Mol Pharmacol 2015; 88: 1085-1092
92. Wielders S, Broers J, ten Cate H, Collins P, Bevers E, Lindhout T. Absence of plateletdependent fibrin formation in a patient with Scott syndrome. Thromb Haemost 2009; 102: 76-82
93. Castoldi E, Collins PW, Williamson PL, Bevers EM. Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome. Blood 2011; 117: 4399-4400
94. Brooks M, Catalfamo J, Brown H, Ivanova P, Lovaglio J. A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity. Blood 2002; 99: 2434-2441
95. Brooks MB, Catalfamo JL, MacNguyen R, Tim D, Fancher S, McCardle JA. A TMEM16F point mutation causes an absence of canine platelet TMEM16F and ineffective activation and death-induced phospholipid scrambling. J Thromb Haemost 2015; 13: 2240-2252
96. Fujii T, Sakata A, Nishimura S, Koji Eto, Nagata S. TMEM16F is required for phosphatidylserine exposure and microvesicle release in activated mouse platelets. Proc Nat Acad Sci USA 2015; 112: 12800-12805
97. Miyanishi M, Segawa K, Nagata S. Synergistic effect of Tim4 and MFG-E8 null mutations on the development of autoimmunity. Int Immunol 2012; 24: 551-559
98. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004; 304: 1147-1150
99. Asano K, Miwa M, Miwa K, Hanayama R, Nagase H, Nagata S et al. Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J Exp Med 2004; 200: 459-467
100. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001; 411: 207-211
101. Behrens EM, Gadue P, Gong SY, Garrett S, Stein PL, Cohen PL. The mer receptor tyrosine kinase: Expression and function suggest a role in innate immunity. Eur J Immunol 2003; 33: 2160-2167
102. Stowell SR, Karmakar S, Stowell CJ, Dias-Baruffi M, McEver RP, Cummings RD. Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells. Blood 2007; 109: 219-227
103. Martin S, Pombo I, Poncet P, David B, Arock M, Blank U. Immunologic stimulation of mast cells leads to the reversible exposure of phosphatidylserine in the absence of apoptosis. Int Arch Aller Imm 2000; 123: 249-258
104. Elliott JI, Surprenant A, Marelli-Berg FM, Cooper JC, Cassady-Cain RL, Wooding C et al. Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol 2005; 7: 808-816
105. De Vries KJ, Wiedmer T, Sims PJ, Gadella BM. Caspase-independent exposure of aminophospholipids and tyrosine phosphorylation in bicarbonate responsive human sperm cells. Biol Reprod 2003; 68: 2122-2134
106. Gadella BM, Harrison RA. Capacitation induces cyclic adenosine 3', 5'-monophosphatedependent, but apoptosis-unrelated, exposure of aminophospholipids at the apical head plasma membrane of boar sperm cells. Biol Reprod 2002; 67: 340-350
107. Lutz HU, Bogdanova A. Mechanisms tagging senescent red blood cells for clearance in healthy humans. Front Physiol 2013; 4: 387
108. Karmakar S, Cummings RD, McEver RP. Contributions of Ca2+ to galectin-1-induced exposure of phosphatidylserine on activated neutrophils. J Biol Chem 2005; 280: 28623-28631
109. Smrz D, Draberova L, Draber P. Non-apoptotic phosphatidylserine externalization induced by engagement of glycosylphosphatidylinositol-anchored proteins. J Biol Chem 2007; 282: 10487-10497
110. Taylor SRJ, Gonzalez-Begne M, Dewhurst S, Chimini G, Higgins CF, Melvin JE et al. Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death. J Immunol 2008; 180: 300-308
111. Yoshida H, Kawane K, Koike M, Mori Y, Uchiyama Y, Nagata S. Phosphatidylserinedependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature 2005; 437: 754-758
112. Hanayama R, Nagata S. Impaired involution of mammary glands in the absence of milk fat globule EGF factor 8. Proc Natl Acad Sci USA 2005; 102: 16886-16891
113. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9: 581-593
114. Amara A, Mercer J. Viral apoptotic mimicry. Nat Rev Microbiol 2015; 13: 461-469
115. Stafford JH, Thorpe PE. Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium. Neoplasia 2011; 13: 299-308
116. Ran S, Downes A, Thorpe PE. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res 2002; 62: 6132-6140
117. Huang X, Bennett M, Thorpe PE. A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice. Cancer Res 2005; 65: 4408-4416
118. Zörnig M, Grzeschiczek A, Kowalski M-B, Hartmann KU, Möröy T. Loss of Fas/Apo-1 receptor accelerates lymphogenesis in Em L-MYC transgenic mice but not in animals infected with MoMuLV. Oncogene 1995; 10: 2397-2401
119. Digumarti R, Bapsy PP, Suresh AV, Bhattacharyya GS, Dasappa L, Shan JS et al. Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer. Lung Cancer 2014; 86: 231-236
120. Chalasani P, Marron M, Roe D, Clarke K, Iannone M, Livingston RB et al. A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer. Cancer Med 2015; 4: 1051-1059
121. Yin Y, Huang X, Lynn KD, Thorpe PE. Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation. Cancer Immunol Res 2013; 1: 256-268
122. Gong EY, Park E, Lee HJ, Lee K. Expression of Atp8b3 in murine testis and its characterization as a testis specific P-type ATPase. Reproduction 2009; 137: 345-351
123. Naito T, Takatsu H, Miyano R, Takada N, Nakayama K, Shin HW. Phospholipid flippase ATP10A translocates phosphatidylcholine and is involved in plasma membrane dynamics. J Biol Chem 2015; 290: 15004-15017
124. Takatsu H, Tanaka G, Segawa K, Suzuki J, Nagata S, Nakayama K et al. Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane. J Biol Chem 2014; 289: 33543-33556
125. Paulusma C, Folmer D, Ho-Mok K, De Waart D, Hilarius P, Verhoeven A et al. ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity. Hepatology 2008; 47: 268-278
126. Ray NB, Durairaj L, Chen BB, McVerry BJ, Ryan AJ, Donahoe M et al. Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia. Nat Med 2010; 16: 1120-1127
127. Munchau A, Valente EM, Davis MB, Stinton V, Wood NW, Quinn NP et al. A Yorkshire family with adult-onset cranio-cervical primary torsion dystonia. Mov Disord 2000; 15: 954-959
128. Charlesworth G, Plagnol V, Holmström KM, Bras J, Sheerin U-M, Preza E et al. Mutations in ANO3 cause dominant craniocervical dystonia: Ion channel implicated in pathogenesis. Am J Hum Genet 2012; 91: 1041-1050
129. Tsutsumi S, Kamata N, Vokes T, Maruoka Y, Nakakuki K, Enomoto S et al. The novel gene encoding a putative transmembrane protein is mutated in gnathodiaphyseal dysplasia (GDD). Am J Hum Genet 2004; 74: 1255-1261
130. Savarese M, Di Fruscio G, Tasca G, Ruggiero L, Janssens S, De Bleecker J et al. Next generation sequencing on patients with LGMD and nonspecific myopathies: Findings associated with ANO5 mutations. Neuromuscular Disord 2015; 25: 533-541
131. Vermeer S, Hoischen A, Meijer RPP, Gilissen C, Neveling K, Wieskamp N et al. Targeted next-generation sequencing of a 12.5 Mb homozygous region reveals ANO10 mutations in patients with autosomal-recessive cerebellar ataxia. Am J Hum Genet 2010; 87: 813-819
132. Balreira A, Boczonadi V, Barca E, Pyle A, Bansagi B, Appleton M et al. ANO10 mutations cause ataxia and coenzyme Q(1)(0) deficiency. J Neurol 2014; 261: 2192-2198
133. Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F et al. McLeod neuroacanthocytosis: Genotype and phenotype. Ann Neurol 2001; 50: 755-764